Intellectual Disability
|
0.200 |
GeneticVariation
|
group |
BEFREE |
In this patient, four genes (MOCS3, DPM1, ADNP, BCAS4) are deleted, which were not affected in the other three cases, suggesting that the deletion of one or more of these genes contributes to the mental retardation.
|
17623483 |
2007 |
Mental Retardation
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In this patient, four genes (MOCS3, DPM1, ADNP, BCAS4) are deleted, which were not affected in the other three cases, suggesting that the deletion of one or more of these genes contributes to the mental retardation.
|
17623483 |
2007 |
Multiple Sclerosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ADNP mRNA was reduced in MS compared to control peripheral blood.
|
19923857 |
2010 |
Schizophrenia
|
0.360 |
Biomarker
|
disease |
BEFREE |
To evaluate a possible involvement of ADNP and ADNP2 in the pathophysiology of schizophrenia in humans, we measured relative brain mRNA transcripts of both proteins compared with control subjects.
|
20598862 |
2011 |
Tauopathies
|
0.030 |
Biomarker
|
group |
BEFREE |
ADNP haploinsufficiency in mice results in tauopathy and cognitive deficits ameliorated by davunetide treatment.
|
22956189 |
2012 |
Impaired cognition
|
0.020 |
Biomarker
|
disease |
BEFREE |
ADNP haploinsufficiency in mice results in tauopathy and cognitive deficits ameliorated by davunetide treatment.
|
22956189 |
2012 |
Cognition Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
ADNP haploinsufficiency in mice results in tauopathy and cognitive deficits ameliorated by davunetide treatment.
|
22956189 |
2012 |
Schizophrenia
|
0.360 |
AlteredExpression
|
disease |
BEFREE |
ADNP haploinsufficiency in mice, which results in age-related neuronal death, cognitive and social dysfunction, exhibited reduced hippocampal beclin1 and increased Bcl2 expression (mimicking schizophrenia and normal human aging).
|
24365867 |
2015 |
Intellectual Disability
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Here, we report ten patients with ASD and other shared clinical characteristics, including intellectual disability and facial dysmorphisms caused by a mutation in ADNP, a transcription factor involved in the SWI/SNF remodeling complex.
|
24531329 |
2014 |
Autism Spectrum Disorders
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
Here, we report ten patients with ASD and other shared clinical characteristics, including intellectual disability and facial dysmorphisms caused by a mutation in ADNP, a transcription factor involved in the SWI/SNF remodeling complex.
|
24531329 |
2014 |
Autistic Disorder
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism.
|
25169753 |
2014 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
BEFREE |
Also, ADNP was found to be mutated in an autism/ID syndrome.
|
25169878 |
2014 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
BEFREE |
ADNP is discovered here as unique to chordata with specific autism mutations different from cancer-associated mutation.
|
25428252 |
2015 |
Alzheimer's Disease
|
0.070 |
Biomarker
|
disease |
BEFREE |
The recent finding of activity-dependent neuroprotective protein (ADNP) as a protein decreased in serum of patients with Alzheimer's disease (AD) compared to controls, alongside with the discovery of ADNP mutations in autism and coupled with the original description of cancer mutations, ignited an interest for a comparative analysis of ADNP with other AD/autism/cancer-associated genes.
|
25428252 |
2015 |
Malignant Neoplasms
|
0.030 |
GeneticVariation
|
group |
BEFREE |
ADNP is discovered here as unique to chordata with specific autism mutations different from cancer-associated mutation.
|
25428252 |
2015 |
Primary malignant neoplasm
|
0.030 |
GeneticVariation
|
group |
BEFREE |
ADNP is discovered here as unique to chordata with specific autism mutations different from cancer-associated mutation.
|
25428252 |
2015 |
Autism Spectrum Disorders
|
0.090 |
Biomarker
|
disease |
BEFREE |
Activity-dependent neuroprotective protein (ADNP) is a most frequent autism spectrum disorder (ASD)-associated gene and the only protein significantly decreasing in the serum of Alzheimer's disease (AD) patients.
|
25646590 |
2015 |
Alzheimer's Disease
|
0.070 |
Biomarker
|
disease |
BEFREE |
Activity-dependent neuroprotective protein (ADNP) is a most frequent autism spectrum disorder (ASD)-associated gene and the only protein significantly decreasing in the serum of Alzheimer's disease (AD) patients.
|
25646590 |
2015 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP.
|
25955282 |
2016 |
Tauopathies
|
0.030 |
Biomarker
|
group |
BEFREE |
Our protein interaction studies identified ADNP as a member of the chromatin remodeling complex, SWI/SNF also associated with alternative splicing of tau and prediction of tauopathy.
|
25955282 |
2016 |
ADNP-related multiple congenital anomalies, intellectual disability, autism spectrum disorder
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
ADNP key functions extend from mice to men, with mutations causing ADNP-related ID/autism syndrome, also known as the Helsmoortel-Van der Aa syndrome.
|
27870441 |
2017 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
BEFREE |
Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease.
|
27870441 |
2017 |
Schizophrenia
|
0.360 |
Biomarker
|
disease |
BEFREE |
It is important to note that ADNP is sexually regulated in the brains of birds, mice, and men and in lymphocytes of patients suffering from schizophrenia.
|
27870441 |
2017 |
Alzheimer's Disease
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
ADNP mRNA increases in lymphocytes derived from schizophrenia patients and in patients suffering from mild cognitive impairment (MCI) and further increases in Alzheimer's disease patients compared with controls.Serum ADNP levels correlate with IQ.
|
27870441 |
2017 |
Mild cognitive disorder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ADNP mRNA increases in lymphocytes derived from schizophrenia patients and in patients suffering from mild cognitive impairment (MCI) and further increases in Alzheimer's disease patients compared with controls.Serum ADNP levels correlate with IQ.
|
27870441 |
2017 |